Nifedipine XL Versus Placebo for the Treatment of Preeclampsia With Severe Features During Induction of Labor

PHASE4CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

June 9, 2020

Primary Completion Date

April 20, 2022

Study Completion Date

May 10, 2022

Conditions
Preeclampsia Severe
Interventions
DRUG

Nifedipine 30 MG

Nifedipine XL is a long-acting medication used to lower blood pressure. The investigators want to learn whether women who receive the study drug will experience fewer severe-range blood pressure readings, and therefore need fewer intravenous (IV) medications to safely lower blood pressure.

DRUG

Placebos

At the time of enrollment, patients will be randomized to either the study drug (oral Nifedipine XL 30mg) or identical placebo.

Trial Locations (1)

43210

The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine, Columbus

All Listed Sponsors
lead

Ohio State University

OTHER

NCT04392375 - Nifedipine XL Versus Placebo for the Treatment of Preeclampsia With Severe Features During Induction of Labor | Biotech Hunter | Biotech Hunter